Table 1 |
|||||||
|
Examples of artemisinin-based monotherapies and combinations currently sold in Africa for the treatment of uncomplicated falciparum malaria with summarized informations provided by the manufacturer on the accompanying package insert. |
|||||||
| Trade name |
Drug substance/s |
Tablet strength (mg) |
Adult dose/s (mg/day) |
Paediatric dose/s (mg/day) |
Duration (days) |
Tablets/package |
Company |
|
|
|||||||
| Combination products |
|||||||
| Artekin – 02 |
dihydroartemisinin+ piperaquine |
40/320 |
160/1280 |
7–10 y 80/640 11–15 y 60/480 |
2 |
8 |
Hualijian |
| Artekin |
dihydroartemisinin+ piperaquine |
40/320 |
160/1280 |
7–10 y 80/640 11–15 y 60/480 |
2 |
8 |
Holleykin pharmaceutical |
| Duo-cotecxin |
dihydroartemisinin+ piperaquine |
40/320 |
160/1280 |
7–10 y 80/640 11–15 60/480 |
2 |
8 |
Beijing Holley-Cotec |
| Coartem |
artemether+ lumefantrine |
20/120 |
D1 160/960, D2-3 80/480 or D1-3 160/960 |
5–15 kg 40/240 16–25 kg 80/480 26–35 kg 120/720 |
3 |
16–24 |
Novartis |
| Artequin |
artesunate + mefloquine |
200/250 |
200/250 |
NA |
3 |
3 + 3 |
Mepha |
| Arsucam (infants and children) |
artesunate + amodiaquine |
50/153 |
NA |
1–7 y 50/153 7–13 y 100/306 |
3 3 |
3 + 3 6 + 6 |
Sanofi-Aventis |
| Arsucam (adults) |
artesunate + amodiaquine |
50/153 |
200/612 |
NA |
3 |
12 + 12 |
Sanofi-Aventis |
| Larimal |
artesunate + amodiaquine |
50/153 |
200/612 |
4 mg/kg (AS) + 10 mg/kg (AM) |
3 |
12 + 12 |
Ipca |
| Monotherapies |
|||||||
| Artesunate tablets |
artesunate |
50 |
D1 200, D2-5 100 |
NA |
5 |
6 |
Guilin pharmaceutical |
| Arinate |
artesunate |
100 |
D1 200, D2-5 100 |
D1 3.2 mg/kg, D2-5 1.6 mg/kg |
5 |
6 |
Dafra |
| Arsumax |
artesunate |
50 |
D1 200, D2-5 100 |
D1 4 mg/kg, D2-5 2 mg/kg |
5 |
12 |
Sanofi-Aventis |
| Cotexin |
artesunate |
60 |
D1 120, D2-5/7 60 |
NA |
5–7 |
NA |
Cotec |
| Artesunate injection |
artesunate |
60 |
NA |
NA |
NA |
NA |
Guilin pharmaceutical |
| Arte-biosorp |
artesunate |
75 |
300 |
NA |
7 |
NA |
Hovid |
| Artenex |
artesunate |
NA |
D1 4tab, D2-5 2tab |
D1 3.2 mg/kg, D2-5 2 mg/kg |
5 |
12 |
Kinapharma |
| Malarin 200 |
artesunate |
200 |
D1 400, D2-5 200 |
D1 4 mg/kg, D2-5 2 mg/kg (infants) D1 200, D2-5 100 (children) |
5 |
6 |
tri-health |
| Plasmotrim 200 |
artesunate |
200 |
D1 400, D2-5 200 |
NA |
5 |
6 |
Mepha |
| Plasmotrim 50 |
artesunate |
50 |
NA |
D1 10 mg/kg, D2-5 5 mg/kg |
5 |
12 |
Mepha |
| Gvither forte kit injection |
artemether |
80 |
D1 240, D2-5 80 |
D1 4 mg/kg, D2-5 2 mg/kg |
5 |
6 |
Gvs labs |
| Gvither forte tablets |
artemether |
80 |
D1 240, D2-5 80 |
D1 4 mg/kg, D2-5 2 mg/kg |
5 |
6 |
Gvs labs |
| Larither capsule |
artemether |
40 |
D1 4 mg/kg, D2-5 2 mg/kg |
NA |
7 |
6 |
Ipca |
| Capsulae artemetheri |
artemether |
40 |
D1 160, D2-5 80 |
NA |
5–7 |
10 |
Kunming pharmaceutical |
| Arte-biosorp |
artemisinin |
75 |
150 |
NA |
7 |
30 |
Hovid |
| Malaxin |
dihydroartemisinin |
60 |
D1 120, D2-5/7 60 |
NA |
7 |
8 |
Cho dang pharmaceutical |
| Cotecxin |
dihydroartemisinin |
60 |
D1 120, D2-5/7 60 |
D1 60, D2-7 30 |
7 |
8 |
Jiaxing nanhu |
|
|
|||||||
|
Abbreviations: NA: information not available. D1,2,3: first, second, third day of treatment. Y: year. Tab: tablets |
|||||||
|
Jackson et al. Malaria Journal 2006 5:81 doi:10.1186/1475-2875-5-81 |
|||||||